Verseon starts dosing in clinical trial of anti-coagulant treatment, 4 Feb 2019 09:57 - Shares magazine

Verseon starts dosing in clinical trial of anti-coagulant treatment, 4 Feb 2019 09:57  Shares magazine

Verseon said dosing had started in a clinical trial for its anti-coagulant treatment for the prevention of stroke and heart attack in coronary artery disease patients.